CYBB and metabolic dysfunction-associated steatotic liver disease: In a study by Albadrani et al. MC administration in adult mice led to NADPH Oxidase 2 (NOX2)- mediated miR21`activation in the liver, that ultimately led to increased hepatic inflammation and fibrogenesis in underlying NAFLD conditions22.